NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hemetron AG

Hemetron AG

Private
ThalwilHealthcare & Life Scienceshttps://hemetron.com/

Last Round

Accelerator

Feb 2, 2026

Total Funding Raised

$222,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hemetron AG is a medical technology company that develops a portable, at-home blood testing platform for monitoring chronic inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Precision Medicine

Business Model

B2B2C

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

RPMremote patient monitoringat-home blood testinghome diagnosticspoint-of-care testingPOCTelectrochemical sensingbiomarker monitoringchronic disease managementmedtechdigital healthCRPC-reactive proteindiagnostic devicehealth IoTprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hemetron AG Comparables

Compare Hemetron AG with similar companies based on industry and business-model similarity.

Hemetron AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bloom Diagnostics
84%
1Drop Diagnostics
80%
Commure
70%

Hemetron AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 2, 2026
SeedDec 6, 2025
GrantSep 1, 2025
GrantJun 1, 2023
AcceleratorSep 14, 2022
Grant
Sep 30, 2021

Key People

Founding team and executive leadership

Alexander Tanno

CEO & Co-Founder

Founding Team

Yves Blickenstorfer

Chief Technology Officer

Executive Team

Hemetron AG Investors

Notable investors and investment history

Hemetron AG investors
InvestorRounds
Gebert Rüf StiftungGrant
Swisspreneur SyndicateSeed
DayOneAccelerator
InnosuisseAccelerator, Grant
Venture KickGrant
Sitem StartUp ClubAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Received funding from Sitem StartUp Club.

  • Jun 1, 2023

    $185K grant received from Gebert Rüf Stiftung.

Hemetron AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hemetron AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hemetron AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersThalwil
Employee Range5
Year Founded2021
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.